BeOne Medicines (ONC) Debt Ratio (2015 - 2026)

BeOne Medicines (ONC) has reported Debt Ratio for 12 consecutive years, with 0.11 the latest figure, recorded in Q1 2026.

• In Q1 2026, Debt Ratio fell 29.09% year-over-year to 0.11; the TTM figure through Mar 2026 stood at 0.11 (down 29.09% YoY), while the FY2025 annual figure was 0.12, down 27.61% from the prior year.
• Debt Ratio slipped to 0.11 in Q1 2026 per ONC's latest filing, from 0.12 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.18 in Q2 2024 and bottomed at 0.03 in Q3 2025.
• Historically, Debt Ratio has averaged 0.12 across 5 years, with a median of 0.11 in 2026.
• Annual changes were most pronounced in 2023 — Debt Ratio soared 222.8% — and 2025, when it sank 86.06%.
• BeOne Medicines' Debt Ratio stood at 0.05 in 2022, then jumped by 222.8% to 0.15 in 2023, then rose by 12.66% to 0.17 in 2024, then declined by 27.61% to 0.12 in 2025, then retreated by 9.92% to 0.11 in 2026.
• Business Quant data shows ONC's Debt Ratio at 0.11 in Q1 2026, 0.12 in Q4 2025, and 0.03 in Q3 2025.